Drug Database
Back to search

Poland· PL-100530217

Allergodil

A azelastine product containing azelastini hydrochloridum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC S01GX07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAllergodilATCS01GX07REGISTER NO.PL-100530217PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about azelastini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azelastine is registered in 10 of 19 countries.

Countries holding a registration under ATC S01GX07 (azelastine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search azelastine products by name

Azelastine · ATC S01GX07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Azelastini hydrochloridum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
S01GX07
ATC class
Azelastine
Defined daily dose
0.1 mg, AT
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991589943

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for azelastine.

Graded by severity as the source publishes them — 1 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azelastine against other medicinesHow interaction checks work

Azelastine · interactions on record

1 record

  • 1 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Azelastine in 13 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All azelastine products

    Authorised across Europe · EMA

    The same active substance is authorised in 28 EEA countries. Names it is sold under:

    • Austria · Allergodil, Allergospray
    • Belgium · Allergodil, Azelergo
    • Bulgaria · Алергодил, Анталерг
    • Czechia · Allergodil, Allergodil Forte
    • Germany · Allergo-Azelind, Allergodil
    • Denmark · Allergodil, Allergodil Forte
    • Estonia · Allergodil
    • Spain · Afluon, Afluón
    • Finland · Lastin
    • France · Allergodil, Alonest
    • United Kingdom (Northern Ireland) · Astepro, Azelair
    • Greece · Afluon
    • Croatia · Vivialle, Vivispray
    • Hungary · Allergodil, Allergodil Forte
    • Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
    • Iceland · Astepro, Lastin
    • Italy · Allergodil, Allespray
    • Lithuania · Allergodil
    • Luxembourg · Allergodil, Azelergo
    • Latvia · Allergodil
    • Malta · Antalerg Unimed Pharma, Azelastin-Comod
    • Netherlands · Allergodil, Allergodil Nevel
    • Norway · Lastin
    • Portugal · Allergodil, Astepro
    • Romania · Allegodil, Allergodil
    • Sweden · Azelastine Omnivision
    • Slovenia · Alezaxin, Allergodil
    • Slovakia · Allergodil, Antalerg

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/50cf44e4-7fcf-40ae-9ff0-447f25409a84
GET /v1/drugs/50cf44e4-7fcf-40ae-9ff0-447f25409a84?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "0,5 mg/ml",
  "packaging": "05909991589943 ¦ OTC ¦ 165009\n1 butelka 6 ml",
  "substance": "Azelastini hydrochloridum 0.5 mg/ml",
  "common_name": "Azelastini hydrochloridum",
  "pl_product_id": "100530217",
  "pozwolenie_nr": "388/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-12-12"
}
    API referenceMCP serverPlans

    See everything about azelastine.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console